Nomura Analyst Sees Fast Growth At BioMarin Pharmaceutical By: Benzinga via Benzinga January 16, 2015 at 15:34 PM EST BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) pipeline and existing products could drive a doubling of revenue every four years, an ... Read More >> Related Stocks: Biomarin Pharmaceuticals